Mastoiditis: Difference between revisions
Jump to navigation
Jump to search
Category |
|||
Line 30: | Line 30: | ||
==Treatment== | ==Treatment== | ||
[[Mastoiditis medical therapy|Medical Therapy]] | [[Mastoiditis primary prevention|Primary Prevention]] | [[Mastoiditis secondary prevention|Secondary Prevention]] | [[Mastoiditis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Mastoiditis future or investigational therapies|Future or Investigational Therapies]] | [[Mastoiditis medical therapy|Medical Therapy]] |[[Mastoiditis surgery|surgery]] | [[Mastoiditis primary prevention|Primary Prevention]] | [[Mastoiditis secondary prevention|Secondary Prevention]] | [[Mastoiditis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Mastoiditis future or investigational therapies|Future or Investigational Therapies]] | ||
==References== | ==References== |
Revision as of 16:51, 6 February 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Mastoiditis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Synonyms and keywords: Mastoid inflammation, Mastoid empyema, Inflammation of mastoid
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Mastoiditis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | X ray | CT scan | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy |surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies